Genetics anlysis developer Sequenom is getting a $33 Million cash infusion.
Investors include Pequot Private Equity Fund, ComVest Investment Partners, Lehman Brothers affiliate LB I Group and SiemensVenture Capital GmbH.
Net proceeds from the investment will be used for working capital and implementation of new management strategies to expand the company's products. Among other efforts, it plans to push ahead with work in the area of noninvasive prenatal diagnostics.
No comments:
Post a Comment